STOCK TITAN

[SCHEDULE 13G] Catheter Precision, Inc. Passive Investment Disclosure (>5%)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Catheter Precision, Inc. (VTAK) received a Schedule 13G filing from investor Gregory Castaldo reporting a significant passive ownership stake in its common stock. Castaldo reports beneficial ownership of 176,674 shares of common stock, representing 7.5% of the outstanding shares.

The ownership percentage is calculated based on 2,357,127 shares of Catheter Precision common stock outstanding as verified with the company on February 11, 2026. Castaldo reports sole voting and dispositive power over all 176,674 shares and certifies that the shares are not held for the purpose of changing or influencing control of the company.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) Based on 2,357,127 shares of Common Stock of the Issuer outstanding as verified with the Issuer on February 11, 2026.


SCHEDULE 13G



Gregory Castaldo
Signature:/s/ Gregory Castaldo
Name/Title:Gregory Castaldo
Date:02/11/2026